mechanism 2,751 words KG: ent-gene-83d99ff1
Contents

FUS Gene-Mechanism-Therapy Causal Chain — ALS/FTD

🔬 Protein Info
Gene Symbolent-gene-83d99ff1
Function- Disrupted karyopherin trafficking
InheritanceAutosomal dominant with high penetrance
Age of OnsetTypically 30-50 years (younger than SOD1-ALS)
ProgressionRapid — median survival 2-3 years from onset
Phenotypic VariabilitySome mutations cause ALS-FTD overlap
KG Connections16 knowledge graph edges
DatabasesGeneCardsUniProtNCBI GeneHPASTRING

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

Wikipedia

Related Hypotheses (50)

Programmable Neuronal Circuit Repair via Epigenetic CRISPR
Score: 0.63
TFEB-PGC1α Mitochondrial-Lysosomal Decoupling
Score: 0.62
Vagal Afferent Microbial Signal Modulation
Score: 0.62
Epigenetic Memory Reprogramming for Alzheimer's Disease
Score: 0.61
The Glial Ketone Metabolic Shunt Hypothesis
Score: 0.61
Metabolic Reprogramming via Coordinated Multi-Gene CRISPR Ci
Score: 0.60
Digital Twin-Guided Metabolic Reprogramming
Score: 0.55
Vocal Cord Neuroplasticity Stimulation
Score: 0.52
Microglia-Derived Extracellular Vesicle Engineering for Targ
Score: 0.48
Optogenetic Control of Mitochondrial Transfer Networks
Score: 0.48
Gamma entrainment therapy to restore hippocampal-cortical sy
Score: 0.95
Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.78
CYP46A1 Overexpression Gene Therapy
Score: 0.77
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.76
Near-infrared light therapy stimulates COX4-dependent mitoch
Score: 0.74
PARP1 Inhibition Therapy
Score: 0.74
Circadian Glymphatic Rescue Therapy (Melatonin-focused)
Score: 0.71
Orexin-Microglia Modulation Therapy
Score: 0.71
Purinergic P2Y12 Inverse Agonist Therapy
Score: 0.70
Lysosomal Calcium Channel Modulation Therapy
Score: 0.70
← Prevpg 2/3Next →

Related Analyses (30)

TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Microglial subtypes in neurodegeneration — friend vs foe
neuroscience · archived
CRISPR-based therapeutic approaches for neurodegenerative di
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD AD
neurodegeneration · archived
How do non-cell autonomous effects of autophagy dysfunction
neurodegeneration · completed

Related Experiments (27)

s:** - Single-cell RNA-seq to measure editing efficiency acr
falsification · proposed · Score: 0.40
ALS Regional Onset and Spread: Network-Level Staging Model
clinical · proposed · Score: 0.40
Autophagy Enhancement Drug Screening for Neurodegeneration
clinical · proposed · Score: 0.40
Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT
validation · proposed · Score: 0.40
C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study
clinical · proposed · Score: 0.40

Knowledge Graph (12 edges)

h-0c9e2166ed targets ent-gene-83d99ff1
ent-gene-83d99ff1 targeted_by h-0c9e2166ed
h-297a9dcbfa targets ent-gene-83d99ff1
ent-gene-83d99ff1 targeted_by h-297a9dcbfa
h-a23cc3c8b9 targets ent-gene-83d99ff1
ent-gene-83d99ff1 targeted_by h-a23cc3c8b9
h-4c4bf4a28f targets ent-gene-83d99ff1
ent-gene-83d99ff1 targeted_by h-4c4bf4a28f
ent-gene-83d99ff1 participates_in_pathway R-HSA-72163
ent-gene-83d99ff1 participates_in_pathway R-HSA-72203

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.